On the public citation graph
Predicting clinical trial outcomes using drug bioactivities through graph database integration and machine learning
0 signed · 86 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/minf.201600073openalex-snapshot
BIGCHEM: Challenges and Opportunities for Big Data Analysis in Chemistry
inferredcites →https://doi.org/10.1002/minf.202000013openalex-snapshot
CompoundDB4j: Integrated Drug Resource of Heterogeneous Chemical Databases
inferredcites →https://doi.org/10.1006/jcss.1997.1504openalex-snapshot
A Decision-Theoretic Generalization of On-Line Learning and an Application to Boosting
inferredcites →https://doi.org/10.1007/978-0-387-84858-7openalex-snapshot
The Elements of Statistical Learning: Data Mining, Inference, and Prediction
inferredcites →https://doi.org/10.1007/978-3-030-05282-9openalex-snapshot
Structural Bioinformatics: Applications in Preclinical Drug Discovery Process
inferredcites →https://doi.org/10.1007/s10822-015-9860-5openalex-snapshot
Activity, assay and target data curation and quality in the ChEMBL database
inferredcites →https://doi.org/10.1007/s12072-020-10131-0openalex-snapshot
Sorafenib for advanced hepatocellular carcinoma provides better prognosis after liver transplantation than without liver transplantation
inferredcites →https://doi.org/10.1016/j.csda.2010.11.018openalex-snapshot
An experimental comparison of cross-validation techniques for estimating the area under the ROC curve
inferredcites →https://doi.org/10.1016/j.drudis.2019.12.014openalex-snapshot
Key indicators of phase transition for clinical trials through machine learning
inferredcites →https://doi.org/10.1016/j.sbi.2021.09.003openalex-snapshot
Toward better drug discovery with knowledge graph
inferredcites →https://doi.org/10.1016/j.spl.2018.02.031openalex-snapshot
When small data beats big data
inferredcites →https://doi.org/10.1016/j.ymeth.2014.08.005openalex-snapshot
Molecular fingerprint similarity search in virtual screening
inferredcites →https://doi.org/10.1016/s0031-3203(02)00060-2openalex-snapshot
The global k-means clustering algorithm
inferredcites →https://doi.org/10.1021/acs.jcim.7b00616openalex-snapshot
Mol2vec: Unsupervised Machine Learning Approach with Chemical Intuition
inferredcites →https://doi.org/10.1021/acs.jcim.8b00698openalex-snapshot
A New Approach for Drug Target and Bioactivity Prediction: The Multifingerprint Similarity Search Algorithm (MuSSeL)
inferredcites →https://doi.org/10.1021/ci00057a005openalex-snapshot
SMILES, a chemical language and information system. 1. Introduction to methodology and encoding rules
inferredcites →https://doi.org/10.1021/ci010132ropenalex-snapshot
Reoptimization of MDL Keys for Use in Drug Discovery
inferredcites →https://doi.org/10.1023/b:amai.0000018580.96245.c6openalex-snapshot
Theoretical Comparison between the Gini Index and Information Gain Criteria
inferredcites →https://doi.org/10.1038/536388aopenalex-snapshot
Busting the billion-dollar myth: how to slash the cost of drug development
inferredcites →https://doi.org/10.1038/d41573-019-00074-zopenalex-snapshot
Trends in clinical success rates and therapeutic focus
inferredcites →https://doi.org/10.1038/nrd.2016.230openalex-snapshot
A comprehensive map of molecular drug targets
inferredcites →https://doi.org/10.1038/nrd.2017.70openalex-snapshot
How much do clinical trials cost?
inferredcites →https://doi.org/10.1038/nrd1608openalex-snapshot
Data integration: challenges for drug discovery
inferredcites →https://doi.org/10.1038/nrg3868openalex-snapshot
Methods of integrating data to uncover genotype–phenotype interactions
inferredcites →https://doi.org/10.1038/s41746-019-0148-3openalex-snapshot
Artificial intelligence and machine learning in clinical development: a translational perspective
inferredcites →https://doi.org/10.1056/nejmoa0708857openalex-snapshot
Sorafenib in Advanced Hepatocellular Carcinoma
inferredcites →https://doi.org/10.1093/bioinformatics/btaa799openalex-snapshot
RAINFOREST: a random forest approach to predict treatment benefit in data from (failed) clinical drug trials
inferredcites →https://doi.org/10.1093/bioinformatics/btaa811openalex-snapshot
Padhoc: a computational pipeline for pathway reconstruction on the fly
inferredcites →https://doi.org/10.1093/bioinformatics/btw731openalex-snapshot
Recon2Neo4j: applying graph database technologies for managing comprehensive genome-scale networks
inferredcites →https://doi.org/10.1093/biostatistics/kxy072openalex-snapshot
Corrigendum: Estimation of clinical trial success rates and related parameters
inferredcites →https://doi.org/10.1093/nar/gkaa1100openalex-snapshot
UniProt: the universal protein knowledgebase in 2021
inferredcites →https://doi.org/10.1093/nar/gkaa891openalex-snapshot
Comparative Toxicogenomics Database (CTD): update 2021
inferredcites →https://doi.org/10.1093/nar/gkj067openalex-snapshot
DrugBank: a comprehensive resource for in silico drug discovery and exploration
inferredcites →https://doi.org/10.1093/nar/gkt1031openalex-snapshot
The ChEMBL bioactivity database: an update
inferredcites →https://doi.org/10.1093/nar/gky1075openalex-snapshot
ChEMBL: towards direct deposition of bioassay data
inferredcites →https://doi.org/10.1101/086033openalex-snapshot
Deep learning with feature embedding for compound-protein interaction prediction
inferredcites →https://doi.org/10.1101/2020.10.08.331926openalex-snapshot
A Machine Learning approach for assessing drug development risk
inferredcites →https://doi.org/10.1109/dexa.2015.59openalex-snapshot
Using Neo4j for Mining Protein Graphs: A Case Study
inferredcites →https://doi.org/10.1111/cbdd.13668openalex-snapshot
Prediction of survival rate and effect of drugs on cancer patients with somatic mutations of genes: An AI‐based approach
inferredcites →https://doi.org/10.1111/cbdd.13819openalex-snapshot
Evaluation of the performance of various machine learning methods on the discrimination of the active compounds
inferredcites →https://doi.org/10.1111/cts.12980openalex-snapshot
Approval success rates of drug candidates based on target, action, modality, application, and their combinations
inferredcites →https://doi.org/10.1145/3236009openalex-snapshot
A Survey of Methods for Explaining Black Box Models
inferredcites →https://doi.org/10.1186/1471-2105-16-s5-s1openalex-snapshot
A comparative study of disease genes and drug targets in the human protein interactome
inferredcites →https://doi.org/10.1186/1755-8794-1-48openalex-snapshot
The Comparative Toxicogenomics Database facilitates identification and understanding of chemical-gene-disease associations: arsenic as a case study
inferredcites →https://doi.org/10.1186/s12859-018-2264-5openalex-snapshot
Random forest versus logistic regression: a large-scale benchmark experiment
inferredcites →https://doi.org/10.1186/s12859-020-03937-0openalex-snapshot
Advantages of using graph databases to explore chromatin conformation capture experiments
inferredcites →https://doi.org/10.1186/s13321-015-0098-yopenalex-snapshot
Target prediction utilising negative bioactivity data covering large chemical space
inferredcites →https://doi.org/10.1186/s13321-017-0232-0openalex-snapshot
Beyond the hype: deep neural networks outperform established methods using a ChEMBL bioactivity benchmark set
inferredcites →https://doi.org/10.1186/s13321-020-00430-xopenalex-snapshot
Inductive transfer learning for molecular activity prediction: Next-Gen QSAR Models with MolPMoFiT
inferredcites →https://doi.org/10.1186/s13321-020-00460-5openalex-snapshot
Molecular representations in AI-driven drug discovery: a review and practical guide
inferredcites →https://doi.org/10.1214/ss/1009213726openalex-snapshot
Statistical Modeling: The Two Cultures (with comments and a rejoinder by the author)
inferredcites →https://doi.org/10.13140/rg.2.2.11705.52320openalex-snapshot
Multimodal AI Engine for Clinical Trials Outcome Prediction: Prospective Case Study of Big Pharma for Q2 2020
inferredcites →https://doi.org/10.1371/journal.pcbi.1005968openalex-snapshot
Reactome graph database: Efficient access to complex pathway data
inferredcites →https://doi.org/10.1371/journal.pmed.1001228openalex-snapshot
Clinical Trials Have Gone Global: Is This a Good Thing?
inferredcites →https://doi.org/10.1371/journal.pone.0033677openalex-snapshot
The Database for Aggregate Analysis of ClinicalTrials.gov (AACT) and Subsequent Regrouping by Clinical Specialty
inferredcites →https://doi.org/10.1371/journal.pone.0179130openalex-snapshot
biochem4j: Integrated and extensible biochemical knowledge through graph databases
inferredcites →https://doi.org/10.1517/17460441.2016.1117070openalex-snapshot
An overview of molecular fingerprint similarity search in virtual screening
inferredcites →https://doi.org/10.2139/ssrn.2973611openalex-snapshot
Machine Learning with Statistical Imputation for Predicting Drug Approvals
inferredcites →https://doi.org/10.3389/fchem.2019.00895openalex-snapshot
SPVec: A Word2vec-Inspired Feature Representation Method for Drug-Target Interaction Prediction
inferredcites →https://doi.org/10.3390/molecules24122233openalex-snapshot
Accelerating Drug Discovery by Early Protein Drug Target Prediction Based on a Multi-Fingerprint Similarity Search †
inferredcites →https://doi.org/10.4088/jcp.v66n1016openalex-snapshot
Adjunctive Risperidone in Generalized Anxiety Disorder
inferredcites →https://doi.org/10.4088/jcp.v67n0307openalex-snapshot
An Open-Label Trial of Risperidone Augmentation for Refractory Anxiety Disorders
inferredcites →https://doi.org/10.48550/arxiv.1201.0490openalex-snapshot
Scikit-learn: Machine Learning in Python
inferredcites →https://doi.org/10.48550/arxiv.1301.3781openalex-snapshot
Efficient Estimation of Word Representations in Vector Space
inferredcites →https://doi.org/10.48550/arxiv.1504.07676openalex-snapshot
Explaining the Success of AdaBoost and Random Forests as Interpolating Classifiers
inferredcites →https://doi.org/10.48550/arxiv.1712.02034openalex-snapshot
SMILES2Vec: An Interpretable General-Purpose Deep Neural Network for Predicting Chemical Properties
inferredcites →https://doi.org/10.6084/m9.figshare.18631901openalex-snapshot
Annexure_ClinicalTrials_Prediction_IntegratedData.zip
inferredcites →https://doi.org/10.6084/m9.figshare.18646118openalex-snapshot
Annexure_ClinicalTrials_Prediction_MLSampleData
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.1007/978-3-031-81339-9_3openalex-snapshot
Enhancing Drug Candidate Generation: Comparing Genetic Algorithm and WGAN-GP Approaches
inferred← citeshttps://doi.org/10.1007/s13198-025-03087-7openalex-snapshot
Entropy based data prioritization and validation in clinical trial drug analysis using efficient predefined time adaptive neural networks
inferred← citeshttps://doi.org/10.1016/j.cgh.2025.01.030openalex-snapshot
Artificial Intelligence for Clinical Trial Facilitation, Lessons for Inflammatory Bowel Disease: A Scoping Review
inferred← citeshttps://doi.org/10.1016/j.drudis.2025.104332openalex-snapshot
Enhancing clinical trial outcome prediction with artificial intelligence: a systematic review
inferred← citeshttps://doi.org/10.1016/j.ijmedinf.2025.105798openalex-snapshot
The use of Artificial Intelligence Algorithms in drug development and clinical trials: A scoping review
inferred← citeshttps://doi.org/10.1016/j.jbi.2023.104403openalex-snapshot
Towards electronic health record-based medical knowledge graph construction, completion, and applications: A literature study
inferred← citeshttps://doi.org/10.1021/acscentsci.5c01473openalex-snapshot
From Prompt to Drug: Toward Pharmaceutical Superintelligence
inferred← citeshttps://doi.org/10.1038/s41598-025-19593-4openalex-snapshot
AI-driven drug discovery using a context-aware hybrid model to optimize drug-target interactions
inferred← citeshttps://doi.org/10.1038/s41598-026-39609-xopenalex-snapshot
Success rates of American clinical oncology trials by geographic factors
inferred← citeshttps://doi.org/10.1038/s41746-025-01886-7openalex-snapshot
A scoping review of artificial intelligence applications in clinical trial risk assessment
inferred← citeshttps://doi.org/10.1109/icbiti65527.2025.11500912openalex-snapshot
Machine Learning for Predicting Clinical Trial Outcomes
inferred← citeshttps://doi.org/10.3389/fneur.2025.1615523openalex-snapshot
Harnessing artificial intelligence for brain disease: advances in diagnosis, drug discovery, and closed-loop therapeutics
inferred← citeshttps://doi.org/10.51847/fpj2yxmjekopenalex-snapshot
Deep Survival Models for Oncology Trial Discontinuation Using Target Class, Toxicity Signals, and Protocol Complexity
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.